Figure 5.
Correlation between frequency of joint bleeds and FVIII activity levels. For each participant, the number of treated joint bleeds per 4-week interval was correlated with the median FVIII activity within each interval, as measured using the OS (blue circles) or CS (red circles) assay in BMN 270 clinical trials 270-201 (A) and 270-301 (B). The predicted bleed frequency per 4-week interval was modeled by negative binomial regression for OS activity (blue solid line) and CS activity (red dashed line). Shaded colored areas represent the corresponding 95% CI. No joint bleeds were reported for FVIII activity >50 IU/dL in either assay; these data were included in the modeling but are not shown here.

Correlation between frequency of joint bleeds and FVIII activity levels. For each participant, the number of treated joint bleeds per 4-week interval was correlated with the median FVIII activity within each interval, as measured using the OS (blue circles) or CS (red circles) assay in BMN 270 clinical trials 270-201 (A) and 270-301 (B). The predicted bleed frequency per 4-week interval was modeled by negative binomial regression for OS activity (blue solid line) and CS activity (red dashed line). Shaded colored areas represent the corresponding 95% CI. No joint bleeds were reported for FVIII activity >50 IU/dL in either assay; these data were included in the modeling but are not shown here.

Close Modal

or Create an Account

Close Modal
Close Modal